| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001068143A3 Immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001058526A3 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 05/16/2002 | WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 05/16/2002 | WO2001045663A3 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 05/16/2002 | WO2001041798A9 Induction of immunoglobulin class switching by inactivated viral vaccine |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | US20020059652 Detecting modulators of liver cell propagation, cell differentiation and lymphocyte activity; obtain modulator, incubate with indicator, mix with culture monitor culture for adjustment in activity |
| 05/16/2002 | US20020058839 Methods and compositions for modulating alpha adrenergic receptor activity |
| 05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058787 Mhc binding peptide oligomers and methods of use |
| 05/16/2002 | US20020058709 For therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lungs |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
| 05/16/2002 | US20020058662 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/16/2002 | US20020058653 Administering cyclic polyamine compound to elevate white blood cell (WBC) count |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058627 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 05/16/2002 | US20020058614 Especially administered by direct injection into the afflicted cartilagenous region or joint. |
| 05/16/2002 | US20020058609 Compositions and methods using complexes of calreticulin and antigenic molecules |
| 05/16/2002 | US20020058317 Process for the fusion of dendritic cells with abnormal tissue cells, in particular tumor cells and media for such a process |
| 05/16/2002 | US20020058259 Regulation of human lipoxin A4 receptor-like protein |
| 05/16/2002 | US20020058047 Vaccines |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058034 Treating or ameliorating an autoimmune condition, an allergic reaction or asthma |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | US20020058023 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells. |
| 05/16/2002 | US20020058013 Bacterial flora-controlling agent; periodontal-pocket bacterial flora-controlling agent that will eliminate or convert the bacteria, fungi, viruses and other microbes into a group of symbiotic bacteria. |
| 05/16/2002 | DE10054279A1 Verwendung von Liganden von Todesrezeptoren oder RIP zur Auslösung des Caspase-unabhängigen Zelltods und Verbindungen zur Inhibition des Caspase-unabhängigen Zelltods Use of ligands of death receptors or RIP to trigger the caspase-independent cell death and compounds for inhibition of the caspase-independent cell death |
| 05/16/2002 | CA2429000A1 Adjuvant combination formulations |
| 05/16/2002 | CA2428164A1 Method for the treatment of inflammation |
| 05/16/2002 | CA2428117A1 Immunogenic compositions comprising liver stage malarial antigens |
| 05/16/2002 | CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | CA2426716A1 Acid derivatives useful as serine protease inhibitors |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1205475A1 Flavonoid compounds for use against oxidative stress and UV radiation |
| 05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
| 05/15/2002 | EP1205178A2 Conjugate, method for its production and use thereof |
| 05/15/2002 | EP1205177A2 Conjugate, method for its production and use thereof |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204681A2 Helical cytokine zalpha48 |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204664A1 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204425A2 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 05/15/2002 | EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 05/15/2002 | EP1204421A2 Stress protein-peptide complexes as vaccines against intra-cellular pathogens |
| 05/15/2002 | EP1204420A2 Trehalose producing prokaryotic cells as vaccines |
| 05/15/2002 | EP1204419A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 05/15/2002 | EP1204418A1 Compositions containing muscle-derived active agents |
| 05/15/2002 | EP1167360A9 Human chymase inhibitors |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP0750509B1 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 05/15/2002 | EP0706513B1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 05/15/2002 | EP0610499B1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 05/15/2002 | CN1348983A Kenrel oil composite extracted from plant kernel and its extraction process and application |
| 05/15/2002 | CN1348787A Chinese medicine prepn for treating lupus erythematosus |
| 05/15/2002 | CN1348764A Application of diacid (5-androstene-17-one-3beta-hydroxy) diester in preparing medicine |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084745C Method for preparing 1,3-oxythiapentane and its derivatives |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/14/2002 | US6388052 Amino acid sequence of nuclear factor of activated t lymphocytes, a transcription factor; immunomodulators |
| 05/14/2002 | US6387930 Antiarthritic agents; antiallergens; skin disorders; inflammatory bowel disorders |
| 05/14/2002 | US6387926 Inhibitors of farnesyl protein transferase |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387898 Treatment for CNS injuries |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387888 Prostate cancer |
| 05/14/2002 | US6387883 Method for the prevention and treatment of cachexia and anorexia |
| 05/14/2002 | US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor |
| 05/14/2002 | US6387374 Complex consists essentially of a heat shock protein noncovalently bound to an antigenic molecule |
| 05/14/2002 | CA2354832C Chlorella preparations exhibiting immunomodulating properties |
| 05/14/2002 | CA2251991C Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 05/14/2002 | CA2247105C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic di seases |
| 05/14/2002 | CA2023899C Anti-sense oligonucleotide sequence, anti-rna messenger of tnf alpha, process for its preparation, use as medicament and pharmaceutical composition |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |